U
CaliPharms, Inc. KGET
$0.00 $0.000.00%
Recommendation
--
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)
--

09/30/2014 06/30/2014 03/31/2014 09/30/2013
Revenue 60.00K 33.00K 19.60K --
Total Other Revenue -- -- -- --
Total Revenue 60.00K 33.00K 19.60K --
Cost of Revenue 67.40K 50.80K 24.80K --
Gross Profit -7.40K -17.90K -5.30K --
SG&A Expenses 224.10K 162.00K 328.90K 184.50K
Depreciation & Amortization -- -- -- --
Other Operating Expenses -- -- -- --
Total Operating Expenses 291.50K 212.80K 353.80K 184.50K
Operating Income -231.60K -179.90K -334.20K -184.50K
Income Before Tax -4.18M -1.31M -784.00K -185.00K
Income Tax Expenses -- -- -- --
Earnings from Continuing Operations -4.18M -1.31M -784.00K -185.00K
Earnings from Discontinued Operations -- -- -- --
Extraordinary Item & Accounting Change -- -- -- --
Minority Interest in Earnings -- -- -- --
Net Income -4.18M -1.31M -784.00K -185.00K
EBIT -231.60K -179.90K -334.20K -184.50K
EBITDA -- -- -- --
EPS Basic 0.00 0.00 0.00 --
Normalized Basic EPS 0.00 0.00 0.00 --
EPS Diluted 0.00 0.00 0.00 --
Normalized Diluted EPS 0.00 0.00 0.00 --
Average Basic Shares Outstanding 3.36B 3.08B 3.05B --
Average Diluted Shares Outstanding 3.36B 3.08B 3.05B --
Dividend Per Share -- -- -- --
Payout Ratio -- -- -- --
Weiss Ratings